After raising over US$1 billion for four non-directional structured products from its Asian clients, DBS Private Bank is starting to look at entry points for cash equities. The four direction-neutral structured products — ESG MSCI EM Asia Outperformance Warrant & Note; US Dispersion Trades Warrant & Note; Rising Consumer Index Outperformance Warrant & Note; and TEA Index Outperformance Warrant — have in total raked in…

To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].

Subscriber Only Content

This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.

Login

Subscribe

Indispensable intelligence

Request for a free trial to Asian Private Banker today.

Need help? Please see our FAQ Guide or email [email protected]